Press "Enter" to skip to content

Three must-dos to cure cancer | Timothy Cripe | TEDxColumbus


ever since I was little I’ve been

ever since I was little I’ve been curious about how things work now most

curious about how things work now most

curious about how things work now most kids when they get a new toy they want

kids when they get a new toy they want

kids when they get a new toy they want to play with it but I always just wanted

to play with it but I always just wanted

to play with it but I always just wanted to take it apart but so you know I think

to take it apart but so you know I think

to take it apart but so you know I think that might have made my parents mad but

that might have made my parents mad but

that might have made my parents mad but they it signaled to them that I wanted

they it signaled to them that I wanted

they it signaled to them that I wanted to become a scientist which I did but I

to become a scientist which I did but I

to become a scientist which I did but I also had an event in high school

also had an event in high school

also had an event in high school happened to me that made me want to

happened to me that made me want to

happened to me that made me want to become a childhood cancer doctor and

become a childhood cancer doctor and

become a childhood cancer doctor and that was when my good friends younger

that was when my good friends younger

that was when my good friends younger brother this young boy Steven Daniel

brother this young boy Steven Daniel

brother this young boy Steven Daniel Jeffries was diagnosed with cancer

Jeffries was diagnosed with cancer

Jeffries was diagnosed with cancer Steven died at the age of 8 in 1975 in

Steven died at the age of 8 in 1975 in

Steven died at the age of 8 in 1975 in Columbia Maryland where I grew up from a

Columbia Maryland where I grew up from a

Columbia Maryland where I grew up from a rare type of pediatric cancer it was my

rare type of pediatric cancer it was my

rare type of pediatric cancer it was my first experience of what cancer can do

first experience of what cancer can do

first experience of what cancer can do to a person what cancer can do to a

to a person what cancer can do to a

to a person what cancer can do to a family to a community and I’ve learned a

family to a community and I’ve learned a

family to a community and I’ve learned a lot since then I’ve learned that well it

lot since then I’ve learned that well it

lot since then I’ve learned that well it took me 17 years of training to become a

took me 17 years of training to become a

took me 17 years of training to become a physician scientist and in the 20 plus

physician scientist and in the 20 plus

physician scientist and in the 20 plus years I’ve been practicing and seeing

years I’ve been practicing and seeing

years I’ve been practicing and seeing patients I’ve learned that there’s

patients I’ve learned that there’s

patients I’ve learned that there’s actually reason for hope there’s reason

actually reason for hope there’s reason

actually reason for hope there’s reason for hope because research cures cancer

for hope because research cures cancer

for hope because research cures cancer but we may need to rethink some of the

but we may need to rethink some of the

but we may need to rethink some of the things that we’ve been looking at in

things that we’ve been looking at in

things that we’ve been looking at in terms of developing the others let me

terms of developing the others let me

terms of developing the others let me explain so acute lymphoblastic leukemia

explain so acute lymphoblastic leukemia

explain so acute lymphoblastic leukemia or a ll is the most common type of

or a ll is the most common type of

or a ll is the most common type of cancer in children and this graph shows

cancer in children and this graph shows

cancer in children and this graph shows you the survival or the percentage of

you the survival or the percentage of

you the survival or the percentage of life of patients based on their years

life of patients based on their years

life of patients based on their years since diagnosis and in the year that I

since diagnosis and in the year that I

since diagnosis and in the year that I was Stevens aged 8 1968 the survival of

was Stevens aged 8 1968 the survival of

was Stevens aged 8 1968 the survival of patients with a ll was pretty bad so 50%

patients with a ll was pretty bad so 50%

patients with a ll was pretty bad so 50% of patients you can see from the dotted

of patients you can see from the dotted

of patients you can see from the dotted line only made it two years and only 10%

line only made it two years and only 10%

line only made it two years and only 10% of patients made it six years or more

of patients made it six years or more

of patients made it six years or more but through the careful application of

but through the careful application of

but through the careful application of research that is testing hypotheses this

research that is testing hypotheses this

research that is testing hypotheses this might work better than what we’re doing

might work better than what we’re doing

might work better than what we’re doing rejecting things that didn’t work and

rejecting things that didn’t work and

rejecting things that didn’t work and building on things that did work we were

building on things that did work we were

building on things that did work we were able to double that long term survival

able to double that long term survival

able to double that long term survival by the time I was 12 and we as a medical

by the time I was 12 and we as a medical

by the time I was 12 and we as a medical community continued to work on that

community continued to work on that

community continued to work on that and by the time I turned 17 patients

and by the time I turned 17 patients

and by the time I turned 17 patients diagnosed that year had a remarkable 60

diagnosed that year had a remarkable 60

diagnosed that year had a remarkable 60 percent cure rate we didn’t stop there

percent cure rate we didn’t stop there

percent cure rate we didn’t stop there however over the next several years and

however over the next several years and

however over the next several years and decades we continued to try new things

decades we continued to try new things

decades we continued to try new things as a community as scientists as medicine

as a community as scientists as medicine

as a community as scientists as medicine medical specialists until the year I

medical specialists until the year I

medical specialists until the year I turned 49 when ninety percent of

turned 49 when ninety percent of

turned 49 when ninety percent of patients were cured that’s the most

patients were cured that’s the most

patients were cured that’s the most recent year we have date data for

recent year we have date data for

recent year we have date data for because we have to follow them out five

because we have to follow them out five

because we have to follow them out five to ten years so we think today if you’re

to ten years so we think today if you’re

to ten years so we think today if you’re diagnosed with standard risk acute

diagnosed with standard risk acute

diagnosed with standard risk acute lymphoblastic leukemia of children in

lymphoblastic leukemia of children in

lymphoblastic leukemia of children in childhood you have over 95 percent

childhood you have over 95 percent

childhood you have over 95 percent survival that’s amazing

so my lesson is to trust research we

so my lesson is to trust research we trust science not only to figure out how

trust science not only to figure out how

trust science not only to figure out how things work which I love to do but also

things work which I love to do but also

things work which I love to do but also to make the world a better place to save

to make the world a better place to save

to make the world a better place to save lives but cancer remains the most common

lives but cancer remains the most common

lives but cancer remains the most common cause of death due to twosies and

cause of death due to twosies and

cause of death due to twosies and children so we need to have to have some

children so we need to have to have some

children so we need to have to have some more work to do what do we do about

more work to do what do we do about

more work to do what do we do about patients with advanced cancer like cake

patients with advanced cancer like cake

patients with advanced cancer like cake an 11 year old who came to me with this

an 11 year old who came to me with this

an 11 year old who came to me with this PET scan you can see the outline of her

PET scan you can see the outline of her

PET scan you can see the outline of her image and all the dark spots except what

image and all the dark spots except what

image and all the dark spots except what her bladder is which collects the tracer

her bladder is which collects the tracer

her bladder is which collects the tracer all the other spots are where her tumor

all the other spots are where her tumor

all the other spots are where her tumor spread she had a metastatic sarcoma this

spread she had a metastatic sarcoma this

spread she had a metastatic sarcoma this outcome for patients with metastatic

outcome for patients with metastatic

outcome for patients with metastatic solid tumors or other kinds of leukemias

solid tumors or other kinds of leukemias

solid tumors or other kinds of leukemias like acute myelogenous leukemia is still

like acute myelogenous leukemia is still

like acute myelogenous leukemia is still like a ll was in the 1960s again the

like a ll was in the 1960s again the

like a ll was in the 1960s again the survival based on the years of diagnosis

survival based on the years of diagnosis

survival based on the years of diagnosis and the survival for all patients pretty

and the survival for all patients pretty

and the survival for all patients pretty much with advanced cancer falls

much with advanced cancer falls

much with advanced cancer falls somewhere in this shaded range in 2017

somewhere in this shaded range in 2017

somewhere in this shaded range in 2017 why haven’t we done better well I submit

why haven’t we done better well I submit

why haven’t we done better well I submit to you that the strategy we’ve been

to you that the strategy we’ve been

to you that the strategy we’ve been using for developing drugs is somewhat

using for developing drugs is somewhat

using for developing drugs is somewhat flawed so in order to figure out how to

flawed so in order to figure out how to

flawed so in order to figure out how to do better we have to go back to the

do better we have to go back to the

do better we have to go back to the biology how does cancer work so we all

biology how does cancer work so we all

biology how does cancer work so we all know you’re probably learned in your

know you’re probably learned in your

know you’re probably learned in your high school biology class that the cell

high school biology class that the cell

high school biology class that the cell divides into and those two cells divide

divides into and those two cells divide

divides into and those two cells divide further and further until you get a

further and further until you get a

further and further until you get a massive cancer it’s usually a clonal

massive cancer it’s usually a clonal

massive cancer it’s usually a clonal population similar cells and at some

population similar cells and at some

population similar cells and at some point one of those cells breaks off and

point one of those cells breaks off and

point one of those cells breaks off and goes down the

goes down the

goes down the blood vessel or a lymph channel and

blood vessel or a lymph channel and

blood vessel or a lymph channel and finds another organ like the longer

finds another organ like the longer

finds another organ like the longer liver and starts dividing there that

liver and starts dividing there that

liver and starts dividing there that forms the metastasis like we saw in Kate

forms the metastasis like we saw in Kate

forms the metastasis like we saw in Kate and what we’ve done over the past

and what we’ve done over the past

and what we’ve done over the past several decades is take some of these

several decades is take some of these

several decades is take some of these tumor cells and grow them in a dish or

tumor cells and grow them in a dish or

tumor cells and grow them in a dish or put them in a mouse and test the drugs

put them in a mouse and test the drugs

put them in a mouse and test the drugs in the dish of the mouse and then only

in the dish of the mouse and then only

in the dish of the mouse and then only use those that work in the dish or a

use those that work in the dish or a

use those that work in the dish or a mouse and try them in people but we may

mouse and try them in people but we may

mouse and try them in people but we may be missing a lot with that simplistic

be missing a lot with that simplistic

be missing a lot with that simplistic view of the world we actually know a lot

view of the world we actually know a lot

view of the world we actually know a lot more about cancer than that so I did a

more about cancer than that so I did a

more about cancer than that so I did a keyword search of the word cancer in the

keyword search of the word cancer in the

keyword search of the word cancer in the world’s medical literature and I found

world’s medical literature and I found

world’s medical literature and I found that we’ve published over 3.5 million

that we’ve published over 3.5 million

that we’ve published over 3.5 million publications on cancer and just a

publications on cancer and just a

publications on cancer and just a hundred over 135,000 have been added

hundred over 135,000 have been added

hundred over 135,000 have been added this year alone so we know a lot now I

this year alone so we know a lot now I

this year alone so we know a lot now I haven’t read them all but I have tried

haven’t read them all but I have tried

haven’t read them all but I have tried to look at the literature to figure out

to look at the literature to figure out

to look at the literature to figure out what are some of the key features that

what are some of the key features that

what are some of the key features that we need to be looking at what might

we need to be looking at what might

we need to be looking at what might explain why we haven’t cured some of

explain why we haven’t cured some of

explain why we haven’t cured some of these other cancers and I boiled down to

these other cancers and I boiled down to

these other cancers and I boiled down to three key features and the first one is

three key features and the first one is

three key features and the first one is illustrated in this diagram so this is

illustrated in this diagram so this is

illustrated in this diagram so this is from a publication done by Lee ding and

from a publication done by Lee ding and

from a publication done by Lee ding and then Elaine Mardis Rick Wilson and both

then Elaine Mardis Rick Wilson and both

then Elaine Mardis Rick Wilson and both at Nationwide Children’s Hospital in

at Nationwide Children’s Hospital in

at Nationwide Children’s Hospital in Columbus Ohio and 36 others published a

Columbus Ohio and 36 others published a

Columbus Ohio and 36 others published a few years ago and they were able to

few years ago and they were able to

few years ago and they were able to genetically track individual cells in

genetically track individual cells in

genetically track individual cells in this case in a cute myelogenous leukemia

this case in a cute myelogenous leukemia

this case in a cute myelogenous leukemia patient you can see those cells on the

patient you can see those cells on the

patient you can see those cells on the left and they wear to track how those

left and they wear to track how those

left and they wear to track how those cells did over time and you can see in

cells did over time and you can see in

cells did over time and you can see in this particular patient that grey cell

this particular patient that grey cell

this particular patient that grey cell expanded to become the main dominant

expanded to become the main dominant

expanded to become the main dominant population in that person and then over

population in that person and then over

population in that person and then over time other cells appeared the orange one

time other cells appeared the orange one

time other cells appeared the orange one the pink one and with chemotherapy that

the pink one and with chemotherapy that

the pink one and with chemotherapy that composition changed most of those cells

composition changed most of those cells

composition changed most of those cells disappeared but some of them remained

disappeared but some of them remained

disappeared but some of them remained and then expanded further so later at

and then expanded further so later at

and then expanded further so later at relapse most of the cells are either

relapse most of the cells are either

relapse most of the cells are either orange or the pink with some of the grey

orange or the pink with some of the grey

orange or the pink with some of the grey now these are different cells that

now these are different cells that

now these are different cells that acquire mutations either genetically or

acquire mutations either genetically or

acquire mutations either genetically or epigenetically meaning changes in gene

epigenetically meaning changes in gene

epigenetically meaning changes in gene expression so I like to think of that as

expression so I like to think of that as

expression so I like to think of that as either their hardware their software has

either their hardware their software has

either their hardware their software has been corrupted from a normal cell so

been corrupted from a normal cell so

been corrupted from a normal cell so this gives diversity or heterogeneity

this gives diversity or heterogeneity

this gives diversity or heterogeneity within tumors so you don’t have just all

within tumors so you don’t have just all

within tumors so you don’t have just all that white all those white cells as you

that white all those white cells as you

that white all those white cells as you saw before the second thing is that

saw before the second thing is that

saw before the second thing is that tumors are not just comprised of tumor

tumors are not just comprised of tumor

tumors are not just comprised of tumor cells they actually have a lot of normal

cells they actually have a lot of normal

cells they actually have a lot of normal cells cancer is partner with normal

cells cancer is partner with normal

cells cancer is partner with normal cells they recruit them into their

cells they recruit them into their

cells they recruit them into their microenvironment and they’d cajole them

microenvironment and they’d cajole them

microenvironment and they’d cajole them into doing things for them normal cells

into doing things for them normal cells

into doing things for them normal cells produce substances that help tumors grow

produce substances that help tumors grow

produce substances that help tumors grow that help them resist therapy this is a

that help them resist therapy this is a

that help them resist therapy this is a image from a microscope of a tumor in my

image from a microscope of a tumor in my

image from a microscope of a tumor in my research laboratory where we could say

research laboratory where we could say

research laboratory where we could say stain the cells you can see all the blue

stain the cells you can see all the blue

stain the cells you can see all the blue cancer cells and then in there are brown

cancer cells and then in there are brown

cancer cells and then in there are brown cells and pink cells those are T cells

cells and pink cells those are T cells

cells and pink cells those are T cells of different types they may be in there

of different types they may be in there

of different types they may be in there suppressing immunity or they may be in

suppressing immunity or they may be in

suppressing immunity or they may be in there trying to fight off the cancer

there trying to fight off the cancer

there trying to fight off the cancer because T cells are part of the immune

because T cells are part of the immune

because T cells are part of the immune system we also know there’s a lot of

system we also know there’s a lot of

system we also know there’s a lot of other cells that are normal cells in

other cells that are normal cells in

other cells that are normal cells in them in a 200 macrophages other myeloid

them in a 200 macrophages other myeloid

them in a 200 macrophages other myeloid cells fibroblasts that help feed the

cells fibroblasts that help feed the

cells fibroblasts that help feed the tumor so when we put a cell in the dish

tumor so when we put a cell in the dish

tumor so when we put a cell in the dish and grow it those aren’t there and the

and grow it those aren’t there and the

and grow it those aren’t there and the third thing was an experiment that just

third thing was an experiment that just

third thing was an experiment that just blew me away when I saw it and this was

blew me away when I saw it and this was

blew me away when I saw it and this was done by Juan masa gay in New York a few

done by Juan masa gay in New York a few

done by Juan masa gay in New York a few years ago he stained a tumor green and a

years ago he stained a tumor green and a

years ago he stained a tumor green and a tumor red and implanted them on

tumor red and implanted them on

tumor red and implanted them on different sides of the mouse and after a

different sides of the mouse and after a

different sides of the mouse and after a few days extracted Zoomers looked at him

few days extracted Zoomers looked at him

few days extracted Zoomers looked at him under the microscope and each of them

under the microscope and each of them

under the microscope and each of them was a mixture of green and red so

was a mixture of green and red so

was a mixture of green and red so different sites of tumors are

different sites of tumors are

different sites of tumors are collaborating they’re communicating if

collaborating they’re communicating if

collaborating they’re communicating if one of those diversity corrupted cells

one of those diversity corrupted cells

one of those diversity corrupted cells gets it figures out how to make a better

gets it figures out how to make a better

gets it figures out how to make a better tumor it can pass that information along

tumor it can pass that information along

tumor it can pass that information along to all the other sites in modern-day

to all the other sites in modern-day

to all the other sites in modern-day words we’d probably call this collusion

so that gives us a different strategy a

so that gives us a different strategy a different picture of cancer that I’m not

different picture of cancer that I’m not

different picture of cancer that I’m not only for you now instead of just the two

only for you now instead of just the two

only for you now instead of just the two cells that are the same we know every

cells that are the same we know every

cells that are the same we know every time a cell divides they’re slightly

time a cell divides they’re slightly

time a cell divides they’re slightly different they acquire some corruption

different they acquire some corruption

different they acquire some corruption of their software or their hardware they

of their software or their hardware they

of their software or their hardware they evolve they change and they continue to

evolve they change and they continue to

evolve they change and they continue to do that as they divide and divide so you

do that as they divide and divide so you

do that as they divide and divide so you get a heterogeneous mass that some cells

get a heterogeneous mass that some cells

get a heterogeneous mass that some cells made of I respond to your treatment but

made of I respond to your treatment but

made of I respond to your treatment but some may not and we know that when these

some may not and we know that when these

some may not and we know that when these cells break off and go down their blood

cells break off and go down their blood

cells break off and go down their blood vessel like we saw before and go into a

vessel like we saw before and go into a

vessel like we saw before and go into a different organ those cells start

different organ those cells start

different organ those cells start dividing in that other organ and in that

dividing in that other organ and in that

dividing in that other organ and in that metastatic site they’re evolving they’re

metastatic site they’re evolving they’re

metastatic site they’re evolving they’re changing so what’s in that metastatic

changing so what’s in that metastatic

changing so what’s in that metastatic site is different from what’s in that

site is different from what’s in that

site is different from what’s in that primary site and probably different from

primary site and probably different from

primary site and probably different from all the other metastatic sites and when

all the other metastatic sites and when

all the other metastatic sites and when we take one of those cells and put it in

we take one of those cells and put it in

we take one of those cells and put it in a dish and grow it it continues to

a dish and grow it it continues to

a dish and grow it it continues to evolve it’s now adapting to growth in a

evolve it’s now adapting to growth in a

evolve it’s now adapting to growth in a dish so it changes it’s no longer the

dish so it changes it’s no longer the

dish so it changes it’s no longer the same as what it wasn’t that person if we

same as what it wasn’t that person if we

same as what it wasn’t that person if we put it in a mouse same thing it’s

put it in a mouse same thing it’s

put it in a mouse same thing it’s different so when we’re testing drugs in

different so when we’re testing drugs in

different so when we’re testing drugs in the dish of the mouse without the

the dish of the mouse without the

the dish of the mouse without the presence of normal cells without the

presence of normal cells without the

presence of normal cells without the collusion between different sites where

collusion between different sites where

collusion between different sites where might be kidding ourselves and missing a

might be kidding ourselves and missing a

might be kidding ourselves and missing a lot

lot

lot now these tumor cells when their this

now these tumor cells when their this

now these tumor cells when their this difference should be recognized by the

difference should be recognized by the

difference should be recognized by the immune system which are these blue cells

immune system which are these blue cells

immune system which are these blue cells these T cells coming in from the

these T cells coming in from the

these T cells coming in from the vasculature that normally kill or

vasculature that normally kill or

vasculature that normally kill or destroy infected tissue or tissue that

destroy infected tissue or tissue that

destroy infected tissue or tissue that shouldn’t be there foreign tissue that’s

shouldn’t be there foreign tissue that’s

shouldn’t be there foreign tissue that’s what rejection of organs is and they

what rejection of organs is and they

what rejection of organs is and they should be rejecting the tumor and we see

should be rejecting the tumor and we see

should be rejecting the tumor and we see T cells in the slide like I showed you

T cells in the slide like I showed you

T cells in the slide like I showed you but they’re not doing anything they’re

but they’re not doing anything they’re

but they’re not doing anything they’re inert they’re just they’re put asleep

inert they’re just they’re put asleep

inert they’re just they’re put asleep they’re suppressed and we now know why

they’re suppressed and we now know why

they’re suppressed and we now know why that is we didn’t understand this for

that is we didn’t understand this for

that is we didn’t understand this for many many years but it’s those normal

many many years but it’s those normal

many many years but it’s those normal cells in many cases that are coming into

cells in many cases that are coming into

cells in many cases that are coming into the tumor and they’re producing

the tumor and they’re producing

the tumor and they’re producing substances tgf-beta il-10 PDL one these

substances tgf-beta il-10 PDL one these

substances tgf-beta il-10 PDL one these are molecules that suppress the immune

are molecules that suppress the immune

are molecules that suppress the immune response and don’t allow these T cells

response and don’t allow these T cells

response and don’t allow these T cells to reject the tumor so we need to think

to reject the tumor so we need to think

to reject the tumor so we need to think about that and then finally the

about that and then finally the

about that and then finally the collusion I talked about these tumor

collusion I talked about these tumor

collusion I talked about these tumor sites are exchanging information they’re

sites are exchanging information they’re

sites are exchanging information they’re not only trading tumor cells those red

not only trading tumor cells those red

not only trading tumor cells those red and green cells they’re trading some of

and green cells they’re trading some of

and green cells they’re trading some of these normal cells have been adapted or

these normal cells have been adapted or

these normal cells have been adapted or coerced to do the tumors bidding they’re

coerced to do the tumors bidding they’re

coerced to do the tumors bidding they’re trading those normally those substances

trading those normally those substances

trading those normally those substances that are suppressing immunity

that are suppressing immunity

that are suppressing immunity and it’s a real big conspiracy against

and it’s a real big conspiracy against

and it’s a real big conspiracy against us it cancer metastatic cancer is like

us it cancer metastatic cancer is like

us it cancer metastatic cancer is like an organism living within us conspiring

an organism living within us conspiring

an organism living within us conspiring against us so we need to think about

against us so we need to think about

against us so we need to think about these three features of cancer if we are

these three features of cancer if we are

these three features of cancer if we are going to make progress against advanced

going to make progress against advanced

going to make progress against advanced cancer the corruption of the genetics

cancer the corruption of the genetics

cancer the corruption of the genetics the diversity the coercion of normal

the diversity the coercion of normal

the diversity the coercion of normal cells which aren’t present in a dish and

cells which aren’t present in a dish and

cells which aren’t present in a dish and the collusion between sites that are

the collusion between sites that are

the collusion between sites that are feeding each other and helping each

feeding each other and helping each

feeding each other and helping each other so I challenge the medical

other so I challenge the medical

other so I challenge the medical community whether you’re in the

community whether you’re in the

community whether you’re in the pharmaceutical industry a cancer

pharmaceutical industry a cancer

pharmaceutical industry a cancer scientist whether you’re an advocate

scientist whether you’re an advocate

scientist whether you’re an advocate who’s raising money from projects and

who’s raising money from projects and

who’s raising money from projects and supporting research which we thank you

supporting research which we thank you

supporting research which we thank you ask yourselves is what I’m doing or what

ask yourselves is what I’m doing or what

ask yourselves is what I’m doing or what I supporting addressing at least one if

I supporting addressing at least one if

I supporting addressing at least one if not all three of these features of

not all three of these features of

not all three of these features of cancer because these are gonna what

cancer because these are gonna what

cancer because these are gonna what what’s going to take us to the next

what’s going to take us to the next

what’s going to take us to the next level to cure advanced cancer corruption

level to cure advanced cancer corruption

level to cure advanced cancer corruption coercion and collusion definitely

coercion and collusion definitely

coercion and collusion definitely something since CNN should be interested

something since CNN should be interested

something since CNN should be interested in now what we’re doing in my research

in now what we’re doing in my research

in now what we’re doing in my research laboratory at Nationwide Children’s

laboratory at Nationwide Children’s

laboratory at Nationwide Children’s Hospital here in Columbus is we’re

Hospital here in Columbus is we’re

Hospital here in Columbus is we’re injecting these tumors with live viruses

injecting these tumors with live viruses

injecting these tumors with live viruses the viruses are attenuated meaning

the viruses are attenuated meaning

the viruses are attenuated meaning they’re crippled they don’t cause

they’re crippled they don’t cause

they’re crippled they don’t cause disease they can still infect and kill

disease they can still infect and kill

disease they can still infect and kill some of those tumor cells and we’re

some of those tumor cells and we’re

some of those tumor cells and we’re combining these and that that tricks the

combining these and that that tricks the

combining these and that that tricks the cancer into thinking in the immune

cancer into thinking in the immune

cancer into thinking in the immune system into thinking cancers an

system into thinking cancers an

system into thinking cancers an infection and brings in all those

infection and brings in all those

infection and brings in all those t-cells and when we combine it with

t-cells and when we combine it with

t-cells and when we combine it with drugs that target some of those normal

drugs that target some of those normal

drugs that target some of those normal substances those normal cells we can lay

substances those normal cells we can lay

substances those normal cells we can lay the cancer bare and get some really good

the cancer bare and get some really good

the cancer bare and get some really good shrinkage results and we’re hoping to

shrinkage results and we’re hoping to

shrinkage results and we’re hoping to achieve the same sort of thing in people

achieve the same sort of thing in people

achieve the same sort of thing in people but there’s probably many other ways

but there’s probably many other ways

but there’s probably many other ways that we as a scientific community can

that we as a scientific community can

that we as a scientific community can think about how to address those three

think about how to address those three

think about how to address those three C’s as you can imagine it takes time as

C’s as you can imagine it takes time as

C’s as you can imagine it takes time as you saw several decades to make real

you saw several decades to make real

you saw several decades to make real progress with a ll and it takes money so

progress with a ll and it takes money so

progress with a ll and it takes money so I thought I’d just check in with our

I thought I’d just check in with our

I thought I’d just check in with our National Priorities since it was just

National Priorities since it was just

National Priorities since it was just Halloween we spent over eight billion

Halloween we spent over eight billion

Halloween we spent over eight billion dollars with Abby on Halloween candy

dollars with Abby on Halloween candy

dollars with Abby on Halloween candy which is three billion more than the

which is three billion more than the

which is three billion more than the entire budget of the National Cancer

entire budget of the National Cancer

entire budget of the National Cancer Institute and the National Cancer

Institute and the National Cancer

Institute and the National Cancer Institute is the largest funder public

Institute is the largest funder public

Institute is the largest funder public funder of cancer research in the world

funder of cancer research in the world

funder of cancer research in the world we spent about half that amount on hot

we spent about half that amount on hot

we spent about half that amount on hot dogs each year and point eight billion

dogs each year and point eight billion

dogs each year and point eight billion dollars on July 4th fireworks which is

dollars on July 4th fireworks which is

dollars on July 4th fireworks which is four times the amount the National

four times the amount the National

four times the amount the National Cancer spends

Cancer spends

Cancer spends on children only 4% of the National

on children only 4% of the National

on children only 4% of the National Cancer Institute’s budget goes to

Cancer Institute’s budget goes to

Cancer Institute’s budget goes to children I had the privilege of spending

children I had the privilege of spending

children I had the privilege of spending some time in Washington DC at a

some time in Washington DC at a

some time in Washington DC at a candlelight vigil about two months ago

it was quite a moving experience not

it was quite a moving experience not only were we paying tribute and in

only were we paying tribute and in

only were we paying tribute and in memory of those we lost but we were

memory of those we lost but we were

memory of those we lost but we were trying to raise awareness about cancer

trying to raise awareness about cancer

trying to raise awareness about cancer research and about funding and these are

research and about funding and these are

research and about funding and these are people who know the power of research

people who know the power of research

people who know the power of research because these are people who know the

because these are people who know the

because these are people who know the story about a o/l through research we’ve

story about a o/l through research we’ve

story about a o/l through research we’ve been able to cure áall cancer let’s not

been able to cure áall cancer let’s not

been able to cure áall cancer let’s not stop until we cure all cancer thank you

stop until we cure all cancer thank you

stop until we cure all cancer thank you [Applause]

”

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *